Dear ISF/ION stakeholders,
As Chair of the Board of Directors, International Schizophrenia Foundation, ISF, I have some important news about the ISF that I need to share with you. For the past year, we on the Board of Directors have been assessing future directions for the ISF and its many programs, including the OMT annual conference and Journal (JOM).
Our greatest challenge has been attracting donations and grants to the ISF. We learned that we needed to consolidate the many faces of ISF, as there was great confusion among our stakeholders and in the marketplace at large, as to whom we were and what differentiated us.
As a result, we went through a re-branding process this past year that produced our new name ION, (Integrated Orthomolecular Network, and website, www.ionhealth.ca.
Having undertaken this exercise, fewer people have been enrolling in our paid professional programs and our revenue from our various funders and other fundraising efforts have also continued to decrease, while costs were rising.
We know many organizations are facing similar fundraising challenges. After careful consideration, we had to reconsider our position in the marketplace. With deep regret the Board of Directors decided to dissolve ISF/ION at the beginning of 2017.
However, we have made sure to leave a legacy for ISF/ION. Please see the attached letter that outlines that legacy. With your help, we know orthomolecular treatments will continue in the world.
Rosalie Moscoe, RHN, RNCP
Chair, Board of Directors, ISF/ION